IBDEI0JI ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26225,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26225,1,3,0)
 ;;=3^Post Op Infection
 ;;^UTILITY(U,$J,358.3,26225,1,4,0)
 ;;=4^998.59
 ;;^UTILITY(U,$J,358.3,26225,2)
 ;;=^97081
 ;;^UTILITY(U,$J,358.3,26226,0)
 ;;=368.03^^165^1544^5
 ;;^UTILITY(U,$J,358.3,26226,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26226,1,3,0)
 ;;=3^Amblyopia,Refractive
 ;;^UTILITY(U,$J,358.3,26226,1,4,0)
 ;;=4^368.03
 ;;^UTILITY(U,$J,358.3,26226,2)
 ;;=^265363
 ;;^UTILITY(U,$J,358.3,26227,0)
 ;;=367.31^^165^1544^6
 ;;^UTILITY(U,$J,358.3,26227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26227,1,3,0)
 ;;=3^Anisometropia
 ;;^UTILITY(U,$J,358.3,26227,1,4,0)
 ;;=4^367.31
 ;;^UTILITY(U,$J,358.3,26227,2)
 ;;=^7839
 ;;^UTILITY(U,$J,358.3,26228,0)
 ;;=367.20^^165^1544^7
 ;;^UTILITY(U,$J,358.3,26228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26228,1,3,0)
 ;;=3^Astigmatism,NOS
 ;;^UTILITY(U,$J,358.3,26228,1,4,0)
 ;;=4^367.20
 ;;^UTILITY(U,$J,358.3,26228,2)
 ;;=^11141
 ;;^UTILITY(U,$J,358.3,26229,0)
 ;;=367.0^^165^1544^27
 ;;^UTILITY(U,$J,358.3,26229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26229,1,3,0)
 ;;=3^Hypermetropia
 ;;^UTILITY(U,$J,358.3,26229,1,4,0)
 ;;=4^367.0
 ;;^UTILITY(U,$J,358.3,26229,2)
 ;;=^60139
 ;;^UTILITY(U,$J,358.3,26230,0)
 ;;=367.1^^165^1544^30
 ;;^UTILITY(U,$J,358.3,26230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26230,1,3,0)
 ;;=3^Myopia
 ;;^UTILITY(U,$J,358.3,26230,1,4,0)
 ;;=4^367.1
 ;;^UTILITY(U,$J,358.3,26230,2)
 ;;=^80671
 ;;^UTILITY(U,$J,358.3,26231,0)
 ;;=V43.1^^165^1544^38
 ;;^UTILITY(U,$J,358.3,26231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26231,1,3,0)
 ;;=3^Pseudophakia
 ;;^UTILITY(U,$J,358.3,26231,1,4,0)
 ;;=4^V43.1
 ;;^UTILITY(U,$J,358.3,26231,2)
 ;;=^69114
 ;;^UTILITY(U,$J,358.3,26232,0)
 ;;=367.9^^165^1544^39
 ;;^UTILITY(U,$J,358.3,26232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26232,1,3,0)
 ;;=3^Refractive Error
 ;;^UTILITY(U,$J,358.3,26232,1,4,0)
 ;;=4^367.9
 ;;^UTILITY(U,$J,358.3,26232,2)
 ;;=^35634
 ;;^UTILITY(U,$J,358.3,26233,0)
 ;;=365.04^^165^1544^24
 ;;^UTILITY(U,$J,358.3,26233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26233,1,3,0)
 ;;=3^Glaucoma Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,26233,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,26233,2)
 ;;=^85124
 ;;^UTILITY(U,$J,358.3,26234,0)
 ;;=365.01^^165^1544^26
 ;;^UTILITY(U,$J,358.3,26234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26234,1,3,0)
 ;;=3^Glaucoma Suspect
 ;;^UTILITY(U,$J,358.3,26234,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,26234,2)
 ;;=^340633
 ;;^UTILITY(U,$J,358.3,26235,0)
 ;;=365.71^^165^1544^22
 ;;^UTILITY(U,$J,358.3,26235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26235,1,3,0)
 ;;=3^Glaucoma Mild Stage
 ;;^UTILITY(U,$J,358.3,26235,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,26235,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,26236,0)
 ;;=365.72^^165^1544^23
 ;;^UTILITY(U,$J,358.3,26236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26236,1,3,0)
 ;;=3^Glaucoma Moderate Stage
 ;;^UTILITY(U,$J,358.3,26236,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,26236,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,26237,0)
 ;;=365.73^^165^1544^25
 ;;^UTILITY(U,$J,358.3,26237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26237,1,3,0)
 ;;=3^Glaucoma Severe Stage
 ;;^UTILITY(U,$J,358.3,26237,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,26237,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,26238,0)
 ;;=362.51^^165^1544^1
 ;;^UTILITY(U,$J,358.3,26238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26238,1,3,0)
 ;;=3^AMD,Dry
 ;;^UTILITY(U,$J,358.3,26238,1,4,0)
 ;;=4^362.51
 ;;^UTILITY(U,$J,358.3,26238,2)
 ;;=^268636
 ;;^UTILITY(U,$J,358.3,26239,0)
 ;;=362.52^^165^1544^2
 ;;^UTILITY(U,$J,358.3,26239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26239,1,3,0)
 ;;=3^AMD,Wet/Exudative
 ;;^UTILITY(U,$J,358.3,26239,1,4,0)
 ;;=4^362.52
 ;;^UTILITY(U,$J,358.3,26239,2)
 ;;=^268637
 ;;^UTILITY(U,$J,358.3,26240,0)
 ;;=362.04^^165^1544^13
 ;;^UTILITY(U,$J,358.3,26240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26240,1,3,0)
 ;;=3^DM Mild NPDR
 ;;^UTILITY(U,$J,358.3,26240,1,4,0)
 ;;=4^362.04
 ;;^UTILITY(U,$J,358.3,26240,2)
 ;;=^332787
 ;;^UTILITY(U,$J,358.3,26241,0)
 ;;=362.05^^165^1544^14
 ;;^UTILITY(U,$J,358.3,26241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26241,1,3,0)
 ;;=3^DM Moderate NPDR
 ;;^UTILITY(U,$J,358.3,26241,1,4,0)
 ;;=4^362.05
 ;;^UTILITY(U,$J,358.3,26241,2)
 ;;=^332788
 ;;^UTILITY(U,$J,358.3,26242,0)
 ;;=362.06^^165^1544^16
 ;;^UTILITY(U,$J,358.3,26242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26242,1,3,0)
 ;;=3^DM Severe NPDR
 ;;^UTILITY(U,$J,358.3,26242,1,4,0)
 ;;=4^362.06
 ;;^UTILITY(U,$J,358.3,26242,2)
 ;;=^332789
 ;;^UTILITY(U,$J,358.3,26243,0)
 ;;=362.02^^165^1544^15
 ;;^UTILITY(U,$J,358.3,26243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26243,1,3,0)
 ;;=3^DM PDR
 ;;^UTILITY(U,$J,358.3,26243,1,4,0)
 ;;=4^362.02
 ;;^UTILITY(U,$J,358.3,26243,2)
 ;;=^268610
 ;;^UTILITY(U,$J,358.3,26244,0)
 ;;=441.4^^166^1545^8
 ;;^UTILITY(U,$J,358.3,26244,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26244,1,4,0)
 ;;=4^441.4
 ;;^UTILITY(U,$J,358.3,26244,1,5,0)
 ;;=5^Aortic Aneursym, abdominal
 ;;^UTILITY(U,$J,358.3,26244,2)
 ;;=^269769
 ;;^UTILITY(U,$J,358.3,26245,0)
 ;;=441.2^^166^1545^9
 ;;^UTILITY(U,$J,358.3,26245,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26245,1,4,0)
 ;;=4^441.2
 ;;^UTILITY(U,$J,358.3,26245,1,5,0)
 ;;=5^Aortic Aneursym,Thoracic w/o Rupture
 ;;^UTILITY(U,$J,358.3,26245,2)
 ;;=^269765
 ;;^UTILITY(U,$J,358.3,26246,0)
 ;;=428.0^^166^1545^13
 ;;^UTILITY(U,$J,358.3,26246,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26246,1,4,0)
 ;;=4^428.0
 ;;^UTILITY(U,$J,358.3,26246,1,5,0)
 ;;=5^CHF
 ;;^UTILITY(U,$J,358.3,26246,2)
 ;;=^54758
 ;;^UTILITY(U,$J,358.3,26247,0)
 ;;=433.10^^166^1545^14
 ;;^UTILITY(U,$J,358.3,26247,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26247,1,4,0)
 ;;=4^433.10
 ;;^UTILITY(U,$J,358.3,26247,1,5,0)
 ;;=5^Carotid Artery disease
 ;;^UTILITY(U,$J,358.3,26247,2)
 ;;=^295801
 ;;^UTILITY(U,$J,358.3,26248,0)
 ;;=443.9^^166^1545^31
 ;;^UTILITY(U,$J,358.3,26248,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26248,1,4,0)
 ;;=4^443.9
 ;;^UTILITY(U,$J,358.3,26248,1,5,0)
 ;;=5^PVD
 ;;^UTILITY(U,$J,358.3,26248,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,26249,0)
 ;;=440.21^^166^1545^32
 ;;^UTILITY(U,$J,358.3,26249,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26249,1,4,0)
 ;;=4^440.21
 ;;^UTILITY(U,$J,358.3,26249,1,5,0)
 ;;=5^PVD w/ intermittent claudication
 ;;^UTILITY(U,$J,358.3,26249,2)
 ;;=^293885
 ;;^UTILITY(U,$J,358.3,26250,0)
 ;;=414.00^^166^1545^11
 ;;^UTILITY(U,$J,358.3,26250,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26250,1,4,0)
 ;;=4^414.00
 ;;^UTILITY(U,$J,358.3,26250,1,5,0)
 ;;=5^CAD
 ;;^UTILITY(U,$J,358.3,26250,2)
 ;;=^28512
 ;;^UTILITY(U,$J,358.3,26251,0)
 ;;=433.30^^166^1545^29
 ;;^UTILITY(U,$J,358.3,26251,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26251,1,4,0)
 ;;=4^433.30
 ;;^UTILITY(U,$J,358.3,26251,1,5,0)
 ;;=5^Occ & Sten Mult/Bil Art w/o CRB
 ;;^UTILITY(U,$J,358.3,26251,2)
 ;;=^295803
 ;;^UTILITY(U,$J,358.3,26252,0)
 ;;=433.80^^166^1545^30
 ;;^UTILITY(U,$J,358.3,26252,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26252,1,4,0)
 ;;=4^433.80
 ;;^UTILITY(U,$J,358.3,26252,1,5,0)
 ;;=5^Occ & Sten Precereb Art
 ;;^UTILITY(U,$J,358.3,26252,2)
 ;;=^295804
 ;;^UTILITY(U,$J,358.3,26253,0)
 ;;=444.21^^166^1545^19
 ;;^UTILITY(U,$J,358.3,26253,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26253,1,4,0)
 ;;=4^444.21
 ;;^UTILITY(U,$J,358.3,26253,1,5,0)
 ;;=5^Embolism/Thrombosis UE
 ;;^UTILITY(U,$J,358.3,26253,2)
 ;;=^269789
 ;;^UTILITY(U,$J,358.3,26254,0)
 ;;=444.22^^166^1545^18
 ;;^UTILITY(U,$J,358.3,26254,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26254,1,4,0)
 ;;=4^444.22
 ;;^UTILITY(U,$J,358.3,26254,1,5,0)
 ;;=5^Embolism/Thrombosis LE
 ;;^UTILITY(U,$J,358.3,26254,2)
 ;;=^269790
 ;;^UTILITY(U,$J,358.3,26255,0)
 ;;=454.0^^166^1545^44
 ;;^UTILITY(U,$J,358.3,26255,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26255,1,4,0)
 ;;=4^454.0
 ;;^UTILITY(U,$J,358.3,26255,1,5,0)
 ;;=5^Varicose Vein w/ Ulcer
 ;;^UTILITY(U,$J,358.3,26255,2)
 ;;=^125410
 ;;^UTILITY(U,$J,358.3,26256,0)
 ;;=454.9^^166^1545^43
 ;;^UTILITY(U,$J,358.3,26256,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26256,1,4,0)
 ;;=4^454.9
 ;;^UTILITY(U,$J,358.3,26256,1,5,0)
 ;;=5^Varicose Vein
 ;;^UTILITY(U,$J,358.3,26256,2)
 ;;=^328758
 ;;^UTILITY(U,$J,358.3,26257,0)
 ;;=729.5^^166^1545^22
 ;;^UTILITY(U,$J,358.3,26257,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26257,1,4,0)
 ;;=4^729.5
 ;;^UTILITY(U,$J,358.3,26257,1,5,0)
 ;;=5^Leg Pain
 ;;^UTILITY(U,$J,358.3,26257,2)
 ;;=^89086
 ;;^UTILITY(U,$J,358.3,26258,0)
 ;;=V81.2^^166^1545^35
 ;;^UTILITY(U,$J,358.3,26258,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26258,1,4,0)
 ;;=4^V81.2
 ;;^UTILITY(U,$J,358.3,26258,1,5,0)
 ;;=5^Screen-Cardiovasc NEC
 ;;^UTILITY(U,$J,358.3,26258,2)
 ;;=^295689
 ;;^UTILITY(U,$J,358.3,26259,0)
 ;;=424.0^^166^1545^23
 ;;^UTILITY(U,$J,358.3,26259,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26259,1,4,0)
 ;;=4^424.0
 ;;^UTILITY(U,$J,358.3,26259,1,5,0)
 ;;=5^Mitral Valve Disorders
 ;;^UTILITY(U,$J,358.3,26259,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,26260,0)
 ;;=424.1^^166^1545^10
 ;;^UTILITY(U,$J,358.3,26260,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26260,1,4,0)
 ;;=4^424.1
 ;;^UTILITY(U,$J,358.3,26260,1,5,0)
 ;;=5^Aortic Valve Disorder
 ;;^UTILITY(U,$J,358.3,26260,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,26261,0)
 ;;=424.2^^166^1545^41
 ;;^UTILITY(U,$J,358.3,26261,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26261,1,4,0)
 ;;=4^424.2
 ;;^UTILITY(U,$J,358.3,26261,1,5,0)
 ;;=5^Tricuspid Valve Disorders,Nonrheumatic
 ;;^UTILITY(U,$J,358.3,26261,2)
 ;;=^269715
 ;;^UTILITY(U,$J,358.3,26262,0)
 ;;=424.3^^166^1545^33
 ;;^UTILITY(U,$J,358.3,26262,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,26262,1,4,0)
 ;;=4^424.3
 ;;^UTILITY(U,$J,358.3,26262,1,5,0)
 ;;=5^Pulmonary Valve Disorder
 ;;^UTILITY(U,$J,358.3,26262,2)
 ;;=^101164
